Codexis

Codexis

Biotechnology, 200 Penobscot Dr, Redwood City, California, 94063, United States, 51-200 Employees

codexis.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is CODEXIS

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver platform to discover, develop and enhance novel, high-performance enzymes and other classes of prote...

Read More

map
  • 200 Penobscot Dr, Redwood City, California, 94063, United States Headquarters: 200 Penobscot Dr, Redwood City, California, 94063, United States
  • 2002 Date Founded: 2002
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies
  • Shaw Shaw CEO:   Shaw Shaw

industries-icon Industry: Biotechnology

SIC SIC Code: 2869 | NAICS Code: 325998 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CODEXIS

Codexis Org Chart and Mapping

VP-Level

Robert Sato

SVP, Pharmaceutical Development, Quality & Regulatory

Employees

Margie Borra-Garske

Assoc. Director, Protein Engineering

Gauri Ganpule

Programs and Portfolio Leader

John Nicols

Strategic Advisor and Board Member

Hugh McMullin

Senior Director, Fermentation

Ivana Pačar

Translational Biotherapeutics Intern

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Codexis

Answer: Codexis's headquarters are located at 200 Penobscot Dr, Redwood City, California, 94063, United States

Answer: Codexis's phone number is 65********

Answer: Codexis's official website is https://codexis.com

Answer: Codexis's revenue is $100 Million to $250 Million

Answer: Codexis's SIC: 2869

Answer: Codexis's NAICS: 325998

Answer: Codexis has 51-200 employees

Answer: Codexis is in Biotechnology

Answer: Codexis contact info: Phone number: 65******** Website: https://codexis.com

Answer: Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access